Email Us

Fetal Chromosomal Aneuploidy and Microdeletions/ Microduplications Detection (NIPT-Plus)

Fetal chrmoml aneuploidy and Microdeletions/ Microduplications Detection (NIPT-Plus) can find 100 chromosomal diseases at once, including 3 common chromosomal aneuploidies, 4 sex chromosomal aneuploidies, and 93 microdeletion duplication syndromes.

nipt plus test

Features of Fetal Chrmoml Aneuploidy and Microdeletions/ Microduplications Detection (NIPT-Plus)

Includes testing for 100 different fetal chromosomal disorders
3 fetal trisomy disordersTrisomy 21, Trisomy 18, Trisomy 13
4 sex chromosome disordersTurner syndrome (XO), Klinefelter syndrome (XXY), Supermale-XYY syndrome,
Superfemale-XXX syndrome
6 microdeletion disorders1p36 deletion syndrome, Digeorge syndrome,
Cri du Chat syndrome, Angelman syndrome, Wolf-Hirschhorn syndrome, Prader-Willi syndrome
87 chromosomal deletions or duplication disorders more than 10Mb of DNASmith-Magenis syndrome, Potocki-Shaffer syndrome, Jacobsen syndrome, Yuan-Harel-Lupski syndrome, Potocki-Lupski syndrome,
Cat eye syndrome etc.
  • NIPT-Plus detection program is also available in CapitalBio Medical Lab: users can submit DNA samples and receive a report within 21 days Any microdeletions or microduplications found are immediately linked to the four most popular international chromosomal abnormality databases


  • Built-in, non-invasive prenatal data analysis system with easy report printing for streamlined clinical workflow

Workflow of Fetal Chrmoml Aneuploidy and Microdeletions/ Microduplications Detection (NIPT-Plus)

Workflow of Fetal Chrmoml Aneuploidy and Microdeletions/ Microduplications Detection (NIPT-Plus)

Target Population Fetal Chrmoml Aneuploidy and Microdeletions/ Microduplications Detection (NIPT-Plus)

  • Women who are pregnant and whose fetal chromosomal aneuploidy risk value on a serological screen is between the high-risk cut-off value and 1/1000;

  • Those who cannot undergo interventional prenatal diagnosis due to certain conditions (such as a history of abortion, a current infection with a chronic pathogen, a blood type other than Rh-positive, etc.);

  • Patients who consult after 20+6 weeks of pregnancy have missed the optimal window for serological screening, but still need an assessment of their risk for trisomy 21, trisomy 18, and trisomy 13.

Products
Contact with Capitalbio
Contact Information
Your Inquiries (Expandable)
Instruments
Detection Kits/Reagents
Research Services
Biochip Design & Fabrication
Diagnostic Services
86-10-69002900
Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing